Pediatrics Doctors in Wayne, PA Accepting Medicare

8 Pediatrics doctors found. Showing 1 - 8

David Lloyd Black, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 110 W Lancaster Ave, Suite 200, Wayne, PA 19087 Phone: 610-293-2229

Dr. Rachel Eryn Bagelman, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 101 E Swedesford Rd, Wayne, PA 19087 Phone: 610-688-5437

Emiliano Tatar, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 110 W Lancaster Ave Ste 200, Wayne, PA 19087 Phone: 610-293-2229    Fax: 610-293-2231

Jacalyn S Maller, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 418 E Lancaster Ave, Wayne, PA 19087 Phone: 610-687-3600    Fax: 610-687-1774

Dr. Hilary Field, MB B.CH. M.R.C.P. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 110 W Lancaster Ave, Ste 3, Wayne, PA 19087 Phone: 610-293-2229    Fax: 610-293-2231

Dr. Ruth S. Mooreville, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 110 West Lancaster Avenue, Suite 200, Wayne, PA 19087 Phone: 610-293-2229    Fax: 610-293-2231

Harold M Gordon, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 418 E Lancaster Ave, Wayne, PA 19087 Phone: 610-687-3600    Fax: 610-687-1774

Dr. Jessica Aimee Rosen-pries, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 110 West Lancaster Avenue, Suite 200, Wayne, PA 19087 Phone: 610-293-2229    Fax: 610-293-2231

News Archive

Standard and intensive blood pressure treatments equally effective in controlling acute intracerebral hemorrhage

An international stroke study found that standard and intensive blood pressure treatments were equally effective in the emergency treatment of acute intracerebral hemorrhage, a type of stroke caused by bleeding into the brain.

Statins may modestly reduce blood pressure

The medications known as statins, typically prescribed to lower blood cholesterol levels, may also modestly reduce blood pressure, according to a report in the April 14 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

MedImmune initiates MEDI8897 phase I clinical studies for treatment of RSV infections

AIMM Therapeutics, a leading human therapeutic antibody company, today announced that its partner MedImmune, LLC, the global biologics unit of AstraZeneca, has initiated phase I clinical studies with MEDI8897, a best-in-class antibody for the treatment of respiratory syncytial virus (RSV) infections in young, at risk children.

Researchers reveal pathways that lead to the development of tissue-resident lymphocytes

Researchers from the University of Science and Technology of China) of the Chinese Academy of Science (CAS), teamed up with scientists from Aix Marseille University, discovered that hematopoietic progenitors possessed the differentiation potential to type 1 innate lymphoid cells in adult liver, and dissected the regulation mechanisms of such cell differentiation, revealing the pathways that lead to the development of tissue-resident lymphocytes.

Read more Medical News

› Verified 3 days ago